WOBURN, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2022 before the opening of the U.S. financial markets on Friday, August 12, 2022. The Company will hold a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions.
Conference Call and Webcast Information
| Event: | Biofrontera Inc. Second Quarter 2022 Financial Results and Business Update Conference Call |
| Date: | Friday, August 12, 2022 |
| Time: | 11:00 a.m. Eastern time |
| Conference call: | 1-877-877-1275 (U.S.) 1-412-858-5202 (international) |
| Webcast: | Live and 90-day replay webcast are available here and at www.investors.biofrontera-us.com. |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com
LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com
###
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP)…
WALLINGFORD, Conn., June 18, 2024 /PRNewswire/ -- InsiteOne, a leading provider of cloud-based Vendor Neutral Archive…
BETHLEHEM, Pa., June 18, 2024 /PRNewswire/ -- Young Women's Christian Association of Bethlehem PA ("YWCA…
Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead…
Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration,…
CHICAGO, June 18, 2024 /PRNewswire/ -- WellBe Senior Medical and its affiliated medical groups announce…